Particle Dynamics Completes St. Louis, Missouri, Innovation Center
The new, fully integrated innovation center includes development laboratories and pilot-scale processing rooms housing technologies in Spray Drying, Microencapsulation, Continuous Granulation, and Solid Dosage Form Development.
Designed for a fully integrated and seamless transition of new products to commercial scale, company officials said the new innovation center will streamline process development and enable more rapid commercialization of products into either of the Company's FDA inspected, GMP facilities in St Louis MO and Seymour IN.
In addition to the facility and equipment investments, Particle Dynamics has developed a project management infrastructure, and hired leaders in Technical Operations, Innovation, and Sales to fuel the company's next level of growth; supporting customer success aligned with current market trends.
"This investment is fully aligned with our Vision to provide a fully integrated portfolio of products and services to the global Healthcare industry," said Nicolas Fortin, CEO at Particle Dynamics. "Having advanced technologies such as spray drying, microencapsulation, granulation, and advanced dosage form development under one roof will enable us to more rapidly respond with the right technical solutions to meet the needs of our customers."
"The completion of our Product and Process Innovation Center marks a major milestone in providing innovative solutions for our customers," stated Chad Dykes, Vice President of Technical Operations. "This new center is the latest in our journey to create a more integrated and agile development process. By consolidating development and manufacturing operations under the same leadership, we will move faster through the development, scale-up and commercialization of solutions for our customers."
According to company officials, “completion of the strategic expansion marks a key milestone in Particle Dynamics' transformation to a customer-focused, integrated solution-provider serving the Nutraceutical, OTC, Consumer Health, and Pharmaceutical sectors.”
“ The investment in facilities and talent further aligns the company's innovation and manufacturing resources to more rapidly meet the demanding needs for more innovative functional materials and dosage forms without compromising the Company's impeccable compliance track record.” Officials said. To underscore this, company officials noted Particle Dynamics has received three FDA inspections in the past nine months with zero Form 483 observations.
2019 Top States for Doing Business: Georgia Ranks #1 Sixth Year in a Row
A Heightened Focus on Reshoring
2019 Leading Metro Locations: Pacific and South-Atlantic Metros Dominate the List
COVID-19 and Site Selection in the Near and Long Term
Site Selection 2020: The Importance of “Regional Depth” with Global Reach
34th Annual Corporate Survey & the 16th Annual Consultants Survey